Chebulinic Acid: An Incipient Anticancer Agent.

Recent Pat Anticancer Drug Discov

Department of Pharmaceutical Sciences, Guru Gobind Singh College of Pharmacy, Yamuna Nagar, 135001, Haryana, India.

Published: January 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: ) comprising chebulinic acid as its principle active constituent is used to cure various diseases. and chebulinic acid are used as antimicrobial, antioxidant, antidiabetic, anti-inflammatory, hepatoprotective, antimutagenic, radioprotective, cardioprotective, antiproliferative, antiarthritic, anticaries, and so on.

Objective: The objective of this current study is to give an overview of the recent literature and patents of and chebulinic acid including methods of its isolation/extraction and their application in the prevention of various cancers and other diseases.

Methods: Present research and patents highlighting the anti-cancer potential of and chebulinic acid have been studied and discussed keeping in view the scientific novelty and impact.

Results: Both and chebulinic acid are currently being explored for their anticancer potential and . They are either incorporated alone or in combination with other plants or drugs to show their activity and many clinical trials are also going on various potentials of the plant and chebulinic acid. Novel extraction techniques are also explored and patented. Efforts are being made to improve the bioavailability by developing Novel herbal drug delivery systems of the plant extract or chebulinic acid itself.

Conclusion: Anti-cancer potential of and chebulinic acid may be well established by promising clinical trials and may open new interventions in various tumors. Clinical trials in conjunction with standard therapies are required to explore and validate the actual potential of T. chebula and chebulinic acid respectively.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574892819666230821110429DOI Listing

Publication Analysis

Top Keywords

chebulinic acid
40
clinical trials
12
chebulinic
10
acid
9
anti-cancer potential
8
potential chebulinic
8
acid incipient
4
incipient anticancer
4
anticancer agent
4
agent background
4

Similar Publications

Ethnopharmacological Relevance: Euphorbia fischeriana (EF), an herb used in ethnomedicine for cancerous ascites, particularly in Inner Mongolian practices, is limited by severe enterotoxicity. Traditionally, co-decoction with Terminalia chebula (TC) mitigates this toxicity, but the underlying mechanism is unknown, hindering its rational clinical development.

Aim Of The Study: To elucidate the molecular mechanism by which TC detoxifies EF, providing a scientific basis for developing safer EF-based therapies against malignant ascites.

View Article and Find Full Text PDF

Perennial endemics of mosquito-borne dengue infection affect millions of lives across tropical and subtropical regions every year. Factors like the Earth's rising temperature, climate change, and lack of dengue-specific drugs and vaccines have led to a significant surge in these infections, warranting urgent efforts to develop new antidengue agents. The dengue virus (DENV) envelope exposes approximately 90 E (envelope) protein dimers on its surface, making it a potent target for drug discovery and vaccine development.

View Article and Find Full Text PDF

(CF) is commonly used to make juice, porridge, and also as dietary supplements owing to anti-inflammatory and antioxidant activities. However, astringency affects the palatability and compliance. During taste masking, it is essential to identify astringent mechanism to balance masking needs and efficacy maintenance.

View Article and Find Full Text PDF

This study investigates the usefulness of chemically modified xanthan gum (XG), a natural polysaccharide known for its mucoadhesive and swelling characteristics, in gastroretentive drug delivery systems. XG was modified through amidation using triethanolamine in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) as a coupling agent. The resulting amidated xanthan gum (AXG) exhibited significantly improved physicochemical properties, including reduced hydrophilicity, enhanced thermal stability, and increased crystallinity, as confirmed by FTIR, DSC, XRD, and ^1H NMR analyses.

View Article and Find Full Text PDF

Virtual Screening of Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and In Vitro Validation.

Molecules

April 2025

Guangdong Provincial Key Laboratory of Applied Botany & Key Laboratory of National Forestry and Grassland Administration on Plant Conservation and Utilization in Southern China, South China Botanical Garden, Guangzhou 510650, China.

The transcription factor erythroid 2-related factor 2 (Nrf2) is a central regulator of cellular defense mechanisms against oxidative stress and inflammation. Keap1 (Kelch-like ECH-associated protein 1) regulates Nrf2 activity by ubiquitination-mediated cytoplasmic retention, thereby suppressing its nuclear translocation and subsequent transcriptional activation of genes encoding phase II detoxifying enzymes. Using a structure-based virtual screening approach, we screened ~16,000 natural compounds to identify Keap1-Nrf2 PPI inhibitors.

View Article and Find Full Text PDF